English
Regional settings| Spread | 0.10 | ||||
 Long position overnight feeLong position overnight fee
Trade size with leverage ~ €5,000.00 Short position overnight fee ~ €4,000.00 | -0.022099% | ||||
| Short position overnight fee Short position overnight fee
Trade size with leverage ~ €5,000.00 Short position overnight fee ~ €4,000.00 | -0.000123% | ||||
| Overnight fee time | 21:00 (UTC) | ||||
| Currency | EUR | ||||
| Min traded quantity | 1 | ||||
| Margin | 20 | ||||
| Stock exchange | France | ||||
| Commission on trade1 | 0% |
Information_provided_by_capital
1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information
| Prev. Close | 1.56 |
| Open | 1.64 |
| 1-Year Change | -76.44% |
| Day's Range | 1.64 - 1.84 |
Korian SA, formerly Korian Medica SA, is a France-based company that operates healthcare facilities and medical establishments. The Company's holdings include residential centers for the elderly, offering permanent social care and medical support; follow-up care and rehabilitation centers, including general and specialized centers. Furthermore, the Company offers hospitalization at home, which avoids or shortens the hospitalization process; and home nursing services, which allows the care prescribes by a doctor at home. Korian-Medicas' establishments are located in France, Italy and Germany via its subsidiaries, Segesta S.p.A., Phonix GmBH, Reacti Malt SAS, Sas La Normandie, Sa La Bastide de la tourne, Sas Mapadex La Roseraie, among others.
BRIEF: For the fiscal year ended 31 December 2021, Korian SA revenues increased 14% to EUR4.31B. Net income applicable to common stockholders increased from EUR39.4M to EUR94.6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Basic Earnings per Share excluding Extraordinary Items increased from EUR0.43 to EUR0.90.
06/2010, Stock Dividend, 0.038192 new share for every 1 share held. 10/2020, Rights Issue, 4 new shares for every 15 shares held @ EUR18.1 (Factor: 1.08266).
